Desk›Healthcare› Bal Pharma Ltd
Bal Pharma Ltd
BSE 524824 · NSE BALPHARMA · ISIN INE083D01012 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹84.49
+1.28%
BSE close, 28 August 2026
₹134.52 cr
1.6 cr shares · Micro cap
₹64.90 cr
as published
17.7× · 1.26×
EPS ₹4.77 · BV ₹67.06
310.80 / 6.75
₹ cr, as filed
21
3 selected · 14%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -14.7% |
|---|---|
| Against 52-week low | +41.5% |
| Day change | +1.28% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹4.77 |
|---|---|
| Price / earnings | 17.71× |
| Price / book | 1.26× |
| Book value — derived, price ÷ P/B | ₹67.06 |
| Return on equity | 7.11% |
| Operating margin | 9.51% |
| Net margin | 1.31% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 7.11%
- ROE as published
- 7.11%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 88.43 | 1.16 | 0.73 | 9.51% | 1.31% |
| Mar-26 · Q | 83.92 | 3.70 | 2.60 | 12.40% | 4.41% |
| FY25-26 | 310.80 | 6.75 | 4.27 | 11.01% | 2.17% |
Quarter on quarter
- Revenue, quarter on quarter
- +5.4%
- Net profit, quarter on quarter
- -68.6%
- Operating margin, quarter on quarter
- -289 bps
Disclosure profile 21 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Change in Directorate | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| General | 5 |
| AGM / EGM | 4 |
| Postal Ballot | 2 |
| Allotment | 1 |
| Annual Report | 1 |
| Board Meeting | 1 |
| Clarification | 1 |
| Compliance Certificate | 1 |
| Record Date | 1 |
| Trading Window | 1 |
| Procedural sub-total | 18 |
| Total | 21 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
21 filings · 3 selected · busiest 2026-08-26 and 2026-09-25
Filing rhythm · the twelve most recent
2026-08-262026-10-07
SelectedProcedural
Filings
21 in the window · 4 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulation 2018 for the quarter ended 30th September 2026
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
25 September 2026 ·
Change in Directorate
Change in Designation of Directors and Reconstitution of Statutory Committee with effective from 01st October 2026 as approved members at 39th AGM of Company held on 24th September 2026 ....
Company Update / Change in Directorate View filing →
-
25 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Enclosed Voting Result and Scrutinizers Report of 39th AGM held on 24th September 2026
AGM/EGM / AGM View filing →
-
25 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window from 01st October 2026 till 48 hours after the declaration of the financial result of the Company for the quarter ended 30th September 2026 (Q2)
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Enclosed Proceedings of the AGM of Bal Pharma Limited held on 24th September 2026
AGM/EGM / AGM View filing →
-
10 September 2026 ·
Clarification Regarding Movement In Price
Clarification regarding Movement in Price asper attachment
Company Update / General View filing →
-
10 September 2026 ·
Clarification sought from Bal Pharma Ltd
The Exchange has sought clarification from Bal Pharma Ltd on September 10, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Company Update / Clarification
-
7 September 2026 ·
Allotment
Confirming the Allotment of Convertible Warrants on Preferential basis
Company Update / Allotment of Equity Shares View filing →
-
27 August 2026 ·
Intimation Of Record Date For Final Dividend
In Continuation of Previous intimation hereby informing 17th September 2026 fixed as Record date for payment of final dividend and communication to shareholders regarding TDS on dividend payment
Corp. Action / Record Date View filing →
-
26 August 2026 ·
Reg. 34 (1) Annual Report.
Bal Pharma Limited Annual Report 2026
Others / Reg. 34 (1) Annual Report View filing →
-
26 August 2026 ·
Bal Pharma Limited - Notice Of AGM
39th AGM of the Company Scheduled on 24th September 2026. Notice copy enclosed
AGM/EGM / AGM View filing →
-
26 August 2026 ·
Intimation - 39Th AGM Scheduled On 24Th September 2026
This is to inform that 39th AGM of Bal Pharma Limited Scheduled to be held on Thursday 24th September 2026 at 11.00 AM through VC Mode.
AGM/EGM / AGM View filing →
-
25 August 2026 ·
Clarification With Respect To Tentative Timeline For Utilization Of Net Proceeds Of Preferential Issue
This is in Continuation of Company earlier intimation made in connection with allotment of warrants , hereby clarify that utilization of net proceeds or tenure of warrants is 18 month from ....
Company Update / General View filing →
-
13 August 2026 ·
Newspaper Publications - Unaudited Financial Results 30Th June 2026 And IEPF Notice
In Continuation of Outcome of Board meeting dated August 12 2026 , Published Unaudited Financial result for the quarter ended 30th June 2026 and IEPF Notice in Financial express and Sanjevani ....
Company Update / General View filing →
-
12 August 2026 ·
Financial Result For The Quarter End 30Th June 2026
Enclosed Financial Result for the First quarter ended 30th June 2026 together with Limited Review Report as submitted by Statutory auditor
Result / Financial Results View filing →
-
12 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12 2026
Board of directors of the Company met on Wednesday, August 12 2026 inter alia transacted the following business. 1. Considered and approved the unaudited Financial Results (Standalone ....
Board Meeting / Outcome of Board Meeting View filing →
-
10 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Scrutinizers Report Pertaining to Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23rd 2026.
AGM/EGM / Postal Ballot View filing →
-
10 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Outcome : Result of Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23 , 2026
AGM/EGM / Postal Ballot View filing →
-
5 August 2026 ·
Board Meeting Intimation for Considering Inter-Alia The Unaudited (Standalone And Consolidated) Financial Statements Of The Company For The First Quarter Ended 30Th June 2026 And Other General Business Matters
Bal Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 and other ....
Board Meeting / Board Meeting View filing →
-
30 July 2026 ·
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 : Intimation Regarding Notice Of Postal Ballot
Company Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice
Company Update / General View filing →
-
23 July 2026 ·
Intimation Regarding Corrigendum To The Postal Ballot Notice
In Continuation of Postal Ballot Notice dated 09th July 2026 , Submitting Corrigendum as integral part to the Said Notice.
Company Update / General View filing →
RSS feed for Bal Pharma Ltd · the 50 most recent filings